This book series focuses on current progress in the broad field of medical microbiology, and covers both basic and applied topics related to the study of microbes, their interactions with human and animals, and emerging issues relevant for public health. Original research and review articles present and discuss multidisciplinary findings and developments on various aspects of microbiology, infectious diseases, and their diagnosis, treatment and prevention.
The book series publishes review and original research contributions, short reports as well as guest edited thematic book volumes. All contributions will be published online first and collected in book volumes. There are no publication costs.
Advances in Microbiology, Infectious Diseases and Public Health is a subseries of
Advances in Experimental Medicine and Biology, which has been publishing significant contributions in the field for over 30 years and is indexed in Medline, Scopus, EMBASE, BIOSIS, Biological Abstracts, CSA, Biological Sciences and Living Resources (ASFA-1), and Biological Sciences.
2020 Impact Factor: 2.622. 5 Year Impact Factor: 3.049; Cite Score: 3.9;
Eigenfactor Score: 0.03583; Article Influence Score: 0.602
Personalized nutrition for microbiota correction and metabolism restore
in type 2 diabetes mellitus patients.- Beyond Bone: Infectious diseases and
immunity in parathyroid disorders.- In vitro antimicrobial susceptibility
testing of biofilm-growing bacteria: current and emerging methods.-
Antibiofilm Efficacy of Polihexanide, Octenidine and Sodium
Hypochlorite/Hypochlorous Acid Based Wound Irrigation Solutions against
Staphylococcus aureus, Pseudomonas aeruginosa and a Multispecies Biofilm.-
Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing
Enterobacteriaceae Isolates Collected from Inanimate Hospital Environments in
Addis Ababa, Ethiopia.- Distribution and Antibiotics Resistance Pattern of
Community-Acquired Methicillin-Resistance Staphylococcus aureus in
Southwestern Nigeria.- Ultrastructural and Immunohistochemical Diagnosis of
a Neonatal Herpes Simplex Virus Infection Presenting as Fulminant Hepatitis:
A Case Report.- Antimicrobial Activity of Xibornol and a Xibornol-Based
Formulation Against Gram-Positive Pathogens of the Respiratory Tract.-
Achille Sclavo (1861-1930) and his innovative contributions to Italian
preventive medicine and healthcare policy.- The magnitude of Carbapenemase
and ESBL producing Enterobacteriaceae isolates from patients with Urinary
Tract Infections at Tikur Anbessa Specialized Teaching Hospital, Addis Ababa,
Ethiopia.
Gianfranco Donelli obtained his master degree in Biological Sciences from the Sapienza University of Rome in 1966. From 1967 onwards he worked as researcher at the Istituto Superiore di Sanità (ISS - Italian National Institute of Health) in Rome in the field of molecular biology and ultrastructure of bacteriophages and human intestinal viruses. In 1975 he was appointed Director of the Electron Microscopy Unit and in 1979 he became the Research Director in molecular biology. In 1982 he founded the Laboratory of Ultrastructures of ISS that has been led by him till 1996. In those years his main research interests covered many aspects of cellular microbiology with special reference to the mechanism of action and the pathogenetic role of toxins and other bacterial virulence factors. He has been invited since 1977 to serve as visiting professor in the Universities of Ancona, Naples, Perugia, Rome and Urbino and in 1999, he was appointed full Professor of Microbiology.In thelast two decades Professor Donelli has been appointed Coordinator of the Infectious Diseases Research Project of ISS (1991-1995); Vice-President of the Advisory Committee for Biological and Medical Sciences of the Italian National Research Council (1994 - 1999); International Affairs Officer of the Italian Society of Microbiology and FEMS delegate (2002 - today); President of the Society for Microbial Ecology and Disease (2006 - 2009) and Vice-Chairperson of the Executive Committee of ESCMID Study Group for Biofilms (2009 - 2013). His recent research activity has been mainly focused on biofilm-based healthcare-associated infections and the possible strategies to prevent and counteract the development of microbial biofilms in the human body. Professor Donelli is the author of over 200 full-length papers published in international journals (H-index = 38) and editor of multiple books. Since 2010 he is the Director of the Microbial Biofilm Laboratory at the Fondazione Santa Lucia researchhospital in Rome.
